The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 17, 2018
Filed:
Jan. 16, 2015
Applicant:
Alphabeta Ab, Djursholm, SE;
Inventors:
Roger Strömberg, Stockholm, SE;
Dmytro Honcharenko, Stockholm, SE;
Jyotirmoy Maity, Stockholm, SE;
Alok Juneja, Stockholm, SE;
Firoz Roshan Kurudenkandy, Stockholm, SE;
Jenny Presto, Stockholm, SE;
Lisa Dolfe, Stockholm, SE;
André Fisahn, Stockholm, SE;
Jan Johansson, Stockholm, SE;
Lennart Nilsson, Stockholm, SE;
Assignee:
AlphaBeta AB, Djursholm, SE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 5/02 (2006.01); C07K 5/078 (2006.01); C07K 5/097 (2006.01); A61K 38/00 (2006.01); C07K 5/068 (2006.01); C07K 5/065 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 5/06156 (2013.01); C07K 5/0215 (2013.01); C07K 5/06078 (2013.01); C07K 5/06086 (2013.01); C07K 5/06139 (2013.01); C07K 5/0821 (2013.01); G01N 33/6896 (2013.01); A61K 38/00 (2013.01); G01N 2500/04 (2013.01); G01N 2800/2821 (2013.01);
Abstract
The present invention relates to the field of molecular biochemistry and medicine, and in particular to ligands comprising modified amino acid residues, targeting the amyloid-β peptide associated with Alzheimer's disease for prevention of aggregation, neurotoxicity and use thereof as drugs for treatment of Alzheimer's disease.